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Wediscussaﬂexiblemethodformodelingsurvivaldatausingpenalizedsmoothingsplineswhenthevaluesofcovariateschangefor
the duration of the study. The Cox proportional hazards model has been widely used for the analysis of treatment and prognostic
eﬀects with censored survival data. However, a number of theoretical problems with respect to the baseline survival function
remain unsolved. We use the generalized additive models (GAMs) with B splines to estimate the survival function and select the
optimum smoothing parameters based on a variant multifold cross-validation (CV) method. The methods are compared with the
generalized cross-validation (GCV) method using data from a long-term study of patients with primary biliary cirrhosis (PBC).
1.Introduction
Several prognostic models for PBC data have been developed
using the Cox proportional hazards model, and the values of
all covariates were determined at the time when the patient
entered the study [1]. However, situations may exist in which
the values of covariates change for the duration of the study.
The time-dependent model uses follow-up data to estimate
the eﬀect of the evolution of the covariates during the course
of the disease; see, for example, Cox [2], Altman and Stavola
[3]a n dC o l l e t t[ 4].
Let t be a continuous lifetime variable and x = (x1,...,
xI) a vector of time-ﬁxed covariates. The Cox’s proportional
hazards model postulates that the hazard at time t is the
product of two components [5, 6]
h(t;x) = h0(t)exp
⎡
⎣
I  
i=1
bixi
⎤
⎦,( 1 )
where b = (b1,...,bI) is a vector of coeﬃcients. The propor-
tional hazards assumption is that the baseline hazard h0(t)i s
af u n c t i o no ft but does not involve the values of covariates x
which are measured at the beginning of an interval to predict
short-term survival.
We investigate PBC data for 312 patients who were seen
at the Mayo Clinic and were monitored for the duration of
the study, as described in Murtaugh et al. [7] and Therneau
and Grambsch [8]. The Cox proportional hazards model was
developed based on the relationship between survival and
the patient characteristics observed when the patient entered
the study. The precision of time-ﬁxed models used in PBC
is rather low, partly because these models are based on data
for which the covariates were measured at the time when the
patient entered the study.
For the analysis of data with time-dependent covariates,
however, the survivor function for any individual depends
on time t and the baseline hazard function. This means that
the survivor function cannot be expressed as a power of the
baseline survivor function and is generally diﬃcult to obtain
for any individual; see, for example, Kalbﬂeish and Prentice
[9]andMarubiniandValsecchi[10].TheMayoupdatedmo-
del (e.g., [7]), and the European new version model (e.g., [3,
11, 12]) have been commonly used to improve the accuracy2 Computational and Mathematical Methods in Medicine
Table 1: Values of covariates for deceased patient #9.
Time interval l Midpoint day a
 9 
l Age (year) x
 9 
l1 Prothrombin time (sec) x
 9 
l2 Bilirubin (mg/dL) x
 9 
l3 δ
 9 
l
1 92.0 42.54 11.0 3.2 0
2 272.5 43.04 12.5 7.0 0
3 542.0 43.53 11.2 4.2 0
4 875.0 44.52 14.1 13.5 0
5 1211.5 45.35 11.5 12.0 0
6 1837.0 46.36 11.5 16.2 0
7 2339.0 48.78 13.0 14.8 1
of survival predictions as a function of covariates measured
at any time during the course of the disease. In the present
article, we propose the variant multifold CV method for
GAM when choosing the optimum smoothing parameters in
order to estimate the survival function and predict the short-
term survival (say, for the following six months) at any time
during the course of the disease.
Anotherusefulideainouranalysisistheconceptofcom-
peting risk. There is “liver transplantation” in PBC data as
competing risk. Competing risk has been treated as censored
data. By adding the liver transplantation as one of time-
dependent covariate, one can test the signiﬁcance of liver
transplantation.
2.Model Building
By extending the Cox proportional hazard model (1),
a ﬂexible survival model has been examined
h(t;x) = h0(t)exp
⎡
⎣
I  
i=1
si(xi)
⎤
⎦,( 2 )
where si(xi) is a spline function for the covariate xi [13–
15]. The proportional hazard model (2) used the time-ﬁxed
values of covariates as shown in Dickson et al. [1]. The esti-
mates of hazard ratio by relative survival regression model
[16] with time-dependent covariates are compared with that
of Cox proportional hazard model. A new approach [17, 18]
is proposed with PBC data, aiming to capture nonlinear pat-
terns of bilirubin time courses and their relationship with
survival time of patients. However, because most patients
withPBCmakerepeatedvisitstotheclinic,itisnaturaltoask
the optimum timing of liver transplantation by predicting
short-term survival at any time in the course of the disease.
The time-dependent covariates X
 d 
l = (a
 d 
l ,x
 d 
l1 ,...,
x
 d 
lI ) are provided for patient #d,w h e r ea
 d 
l is the midpoint
of time interval [t
 d 
l ,t
 d 
l+1] for the lth clinic visit. The event
times may be subject to the usual random censoring. Then
only the minimum of survival and censoring time with cen-
soring indicator
δ
 d 
l =
⎧
⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎩
1:p a t i e n t# d died at time-interval
for the lth clinic visit
0 : otherwise
(3)
are observed. The relative hazard h(t)/h0(t) then depends on
time t, and thus the proportional hazards assumption is no
longer satisﬁed, as described in Altman and Stavola [3]a n d
Arjas [19].
Forexample,Table 1 showsthevaluesofage,prothrombin
time,a n dbilirubin as time-dependent covariates for dead
patient #9; for details, see Table 4 in Murtaugh et al. [7]. Pa-
tientswerescheduledtoreturnforfurtherobservationsatsix
months, 12 months, and yearly. Thus, n = 312 patients gene-
rate1945observationsintotal.Thecovariatesvaluesforeach
patient were allowed to vary with the time interval for the lth
clinic visit.
A grouped version of Cox’s proportional hazard model
with time-ﬁxed covariates has been considered in the frame-
work of discrete grouped data for the feed-forward neural
network. Given the continuous survivor time, piecewise mo-
dels arise from the partition of the time axis into disjointed
intervals. Biganzoli et al. [20, 21] show that, by treating the
time interval as an input variable in a feed forward neural
network, it is possible to estimate smoothed discrete hazards
as conditional probabilities of failure. Biganzoli et al. [20]
also pointed out that an advantage of this kind of data struc-
ture is the possibility of straightforward use of time-depen-
dent covariates since each subject is represented, for each ob-
servation interval, by one input vector which can change
across intervals. In order to apply this neural network ap-
proach, which is called partial logistic regression models
[20], discretization of one-month or one-week intervals
must be applied for the continuous survivor time with time-
ﬁxed covariates. We cannot determine which discretization,
one-month or one-week intervals, must be applied; that, is
the discretization is not originally unique. For the data in
Table 1, however, the choice of discretization of the time axis
for the partial logistic regression model is generally deter-
mined by clinical relevance, possibly according to the sche-
duled time intervals between follow-up visits.
The primary goal of the present study is to predict short-
term survival in patients on the basis of measurements of
severalcharacteristicshavingtime-dependentcovariatesX
 d 
l
for the purpose of facilitating the decision as to when to un-
dertake liver transplantation. Based on partial logistic model
due to Cox [22]a n dE f r o n[ 23]f o rt h eg r o u p e dd a t a ,
Tsujitani and Sakon [24] have proposed a partial logistic
model with a discrete hazard rate h<d>
l for ungrouped dataComputational and Mathematical Methods in Medicine 3
having time-dependent covariates
ln
⎛
⎝ h
 d 
l
1 −h
 d 
l
⎞
⎠ = β0 +γt
 d 
l +β1x
 d 
l1 +β2x
 d 
l2 + ···+βIx
 d 
lI ,
d = 1,2,....,n,
(4)
whereβ = (β1,...,βI)isavectorofcoeﬃcients.Themodeled
response is the logit of hazard rate, and the logit is linear
in the covariates. However, this assumption is violated when
covariate eﬀects are best represented by smooth, nonlinear
function. In recent years, a variety of powerful techniques
have been developed for exploring the function form of
eﬀects. We examine here a ﬂexible survival model GAM
that does not require linearity of the covariate function by
extending a generalized linear model (GLM); see, for exam-
ple, Hastie and Tibshirani [13] and McCullagh and Nelder
[25]. By identiﬁcation of nonlinear covariate eﬀects, we
can estimate more accurately a patient’s prognosis and thus
determine a liver transplant based on prediction of short-
term survival.
Thelinearpredictorin(4)isspeciﬁedasasumofsmooth
functions s(x) with twice continuous derivatives of some or
allofthecovariatesforthediscretehazardrateh<d>
l ofpatient
#d at the time interval l
ln
⎛
⎝ h
 d 
l
1 −h
 d 
l
⎞
⎠ = β0 +s0
 
t
 d 
l
 
+s1
 
x
 d 
l1
 
+s2
 
x
 d 
l2
 
+ ···+sI
 
x
 d 
lI
 
.
(5)
The smooth functions in (5)c a nb er e p r e s e n t e da s
s0(x) =
q0  
j=1
βjb0j(t),
s1(x) =
q1  
j=1
βq0+jb1j(x),
...
sI(x) =
qI  
j=1
βqI−1+jbIj(x),
(6)
where q1,q2,...,qI are the numbers of knots, and
β =
 
β0,β1,...,βq0,βq0+1,βq0+2,...,βq0+q1,
...,βq0+q1+···+qI−1+1,βq0+q1+···+qI−1+2,
...,βq0+q1+···+qI
 
,
(7)
Z =
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢
⎣
1 b01(x11) ... b 0q1(x11) · bI−1,q0+q1+···+qI−1+1
 
xI−1,1
 
... b I,q0+q1+···+qI(xI1)
1 b01(x12) ... b 0q1(x12) · bI−1,q0+q1+···+qI−1+1
 
xI−1,2
 
... b I,q0+q1+···+qI(xI2)
··... ·· ... ... ·
1 b01(x11) ... b 0q1(x1n) · bI−1,q0+q1+···+qI−1+1
 
xI−1,n
 
... b I,q0+q1+···+qI(xIn)
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥
⎦
.
(8)
Thefunctionsbij(xij)inthematrixZareB-splinebasisfunc-
tions. Thus, (5)c a nb er e w r i t t e na s
ln
⎛
⎝ h
 d 
l
1 −h
 d 
l
⎞
⎠ = Z β
n×qq ×1
; q =
I  
i=0
qi,( 9 )
where B-splines with 10 interiors knots will be used for each
continuous covariate. The number of knots is arbitrary but
appears to have little eﬀect on the results, provided that the
number is not too small, as described in Gray [15].
At the time interval for the lth clinic visit of patient #d,
we deﬁne
δ
  d 
l =
⎧
⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎩
1:p a t i e n t# d was censored at
time-interval for the lth clinic visit
0 : otherwise,
v
 d 
l =
 
δ
 d 
1 ,δ
  d 
1 ,δ
 d 
2 ,δ
  d 
2 ,...,δ
 d 
l−1,δ
  d 
l−1
 
= (0,0,...,0),
v
  d 
l =
 
v
 d 
l ,δ
 d 
l
 
=
 
0,0,...,0,δ
 d 
l
 
,
(10)
where v
 d 
l is the history of dead and censored of time inter-
valsfortheﬁrstlthclinicvisitofpatient#d,andv
  d 
l = (v
 d 
l ,
δ
 d 
l ) is the same history extended to include δ<d>
l .T s u j i t a n i
and Sakon [24] derived the full log likelihood for all patients
lnL = lnL
 
β
 
+
n  
d=1
ld  
l=1
ln p
 
δ
  d 
l | v
  d 
l
 
(11)
with partial log likelihood
lnL
 
β
 
=
n  
d=1
⎧
⎨
⎩
ld−1  
l=1
ln
 
1 −h
 d 
l
 
+δ
 d 
ld lnh
 d 
ld
+
 
1 −δ
 d 
ld
 
ln
 
1 − h
 d 
ld
 
⎫
⎬
⎭.
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The unknown parameters β in (9) can thus be estimated
by maximizing the partial log likelihood (12), which is the
log likelihood for the independent Bernoulli trial. Although
lnL(β) is not a log likelihood in the usual sense, it possesses
the usual asymptotic properties under fairly broad condi-
tions; see, for example, Andelsen and Gill [26].
T oa v o i do v e r ﬁ t t i n g ,s u c hm o d e l sa r ee s t i m a t e db yp e n a l -
ized maximum likelihood
lnL
 
β
 
=
n  
d=1
⎧
⎨
⎩
ld−1  
l=1
ln
 
1 −h
 d 
l
 
+δ
 d 
ld lnh
 d 
ld
+
 
1 −δ
 d 
ld
 
ln
 
1 −h
 d 
ld
 
⎫
⎬
⎭
+
1
2
I  
i=1
λi
   
s
  
i (t)
 2dt,
(13)
where λi are smoothing parameters that control the tradeoﬀ
between the ﬁt and the smoothness, and s
  
i is the twice deri-
vative of si with respect to t. The advantage of penalized
estimates is enlightened in Wood ([27], Section 4.1).
Two model-ﬁtting issues remain. The ﬁrst concerns the
selection of smoothing parameter λi in (13). The careful
smoothing parameter choice is outweighed by the easy iden-
tiﬁcation of a covariate’s functional form, and the applicabil-
ity of established inferential methods to short-term survival
prediction. In order to select the smoothing parameters, the
algorithm due to Wood [27–29] can be used by minimizing
GCV as an approximation to leaving-one-out CV. For exam-
ple, however, the dead patient #9 generated seven observa-
tions as shown in Table 1. Patients were scheduled to return
for further observations at six months, 12 months, and
yearly. It should be noted that this patient generated seven
observations. Thus, n = 312 patients generate 1945 observa-
tions in total.
We propose a natural extension of v-fold CV algorithm
by “leaving-one-out” CV based on each n = 312 patients.
The ordinal v-fold CV divides the data randomly in v groups
sothattheirsizesareasnearlyequalaspossible.Thepartition
should be made to avoid possible biases, as described in
Zhang[30].Inmanyproblems,theordinalv-foldCVis,thus,
unsatisfactory in several respects for time-dependent covari-
ates. Applying this kind of data structure to the CV algo-
rithm, we obtain insights into how the partition of data
should be done. A natural extension of v-fold CV algorithm
by setting v = n is to allow the deletion of the patient with
several observations. The variant v-fold CV is given as fol-
lows:
Step 1. Split the original sample X ={ X 1 ,...,X d ,...,
X n } into n parts X ={ X 1 |...|X d |...|X n },w h e r e
X d  ={ X
 d 
1 ,...,X
 d 
ld }.
Step 2. Fit the model to X∗ ={ X 1 |...|X d−1 |X d+1 |...|
X n } with the d-th subject (i.e., patient) deleted of the data,
and predict
 ld−1
l=1 ln(1−   h
 d 
l )+δ
 d 
ld ln   h
 d 
ld +(1−δ
 d 
ld )ln(1−
  h
 d 
ld ) for the deleted dth sample X d .
Step 3. Do the above for d = 1,2,...,n and combine the CV
estimates
CV =
n  
d=1
⎧
⎨
⎩
ld−1  
l=1
ln
 
1 −   h
 d 
l
 
+δ
 d 
ld ln   h
 d 
ld
+
 
1 −δ
 d 
ld
 
ln
 
1 −   h
 d 
ld
 
⎫
⎬
⎭.
(14)
A second issue is the goodness-of-ﬁt test of the model.
After choosing the optimum smoothing parameters via
v-fold CV algorithm, the deviance allows us to test the
goodness of ﬁt
Dev = 2(lnLmax − lnLc), (15)
where lnLc denotes the maximized partial log likelihood
under some current GAM, and the log likelihood for the
maximum (full) model lnLmax is zero. The deviance given
by (15) is, however, not even approximately a χ2 distribution
for the case in which ungrouped binary responses are avai-
lable; see, for example, Landwehr et al. [31] and Tsujitani
and Koshimizu [32]a n dC o l l e t t[ 33]. The number of deg-
rees of freedom required for the test for signiﬁcance using
the assumed χ2 distribution for the deviance is a contentious
issue. No adequate distribution theory exists for the devi-
ance. The reason for this is somewhat technical; for details,
see Section 3.8 in Collett [33]. Consequently, the deviance
on ﬁtting a model to binary response data cannot be used as
a summary measure of the goodness-of-ﬁt test of the model.
Based on the above discussion, we employ bootstrapping
to the deviance of (15) in order to obtain the goodness-of-ﬁt
test due to Efron and Tibshirani [34].
Step 1. Generate B bootstrap samples X∗ ={ X
 1 ∗
l ,...,
X
 n ∗
l } from the original sample X.L e tX∗(b) denote the bth
bootstrap sample.
Step 2. For the bootstrap sample X∗(b), the deviance of (15)
is computed by Dev(b) = 2[lnLf −ln(X∗(b);   β
∗
(b))].
This process is repeated independently B times, and the
computed values are arranged in ascending order.
Step 3. The value of the jth order statistic Dev∗ of the B rep-
lications can be taken as an estimate of the quantile of order
j/(B +1 ).
Step 4. The estimate of the 100(1−α)-th percentile (i.e., α%
critical point) of Dev∗ is used to test the goodness-of-ﬁt of a
model having a speciﬁed signiﬁcance level α = 1− j/(B +1).
The value of deviance of (15) being greater than the estimate
of the percentile indicates that the model ﬁts poorly.
3. Results
The survival function for our discretized situation is
S(tl) =
 
1≤i≤l
 
1 −h
 d 
i
 
. (16)Computational and Mathematical Methods in Medicine 5
Table 2: Optimum smoothing parameters.
Covariates Variant v-fold CV GCV
Time 0.1 0.00045
Age 10 0.000015
Prothrombin time 0.001 0.00039
Bilirubin 0.001 0.00000017
Table 3: Test of signiﬁcance for the covariates (P values).
Covariates Variant v-fold CV GCV
Time 0.263 0.0028
Age <0.0001 <0.0001
Prothrombin time <0.0001 <0.0001
Bilirubin <0.0001 <0.0001
The conditional probability Pr(t,t + Δt)o fs u r v i v a lo v e ra
short-time interval Δt (say, six months) after time t can be
estimated as
  Pr(t,Δt) =
  S(t +Δt)
  S(t)
. (17)
By using variant v-fold CV and GCV, the optimum
smoothing parameters for GAM are determined as shown in
Table 2. Table 3 summarizes the P values to test the nonpara-
metric eﬀects of covariates for the model s(time) + s(age)
+ s(pro) + s(bili) with the optimum smoothing parameters
and GCV. From Table 3, all covariates are highly signiﬁcant
for GCV; however, time is not signiﬁcant for variant v-fold
CV. GCV is only the approximation of leaving-one-out CV.
Furthermore, the variant v-fold CV is leaving one-out CV
basedoneachn = 312patients.Sovariantv-foldCVisbetter
than GCV. For the purpose of comparison, we included the
resultsinthecaseusingGCVinTables2and3.Table 4 shows
the results of a number of models that were ﬁt to the data.
The likelihood ratio (LR) statistic based on deviance can
be conducted to test whether the spline eﬀect provides a sig-
niﬁcantly better ﬁt than a linear eﬀect. Table 5 shows the
test of signiﬁcance for spline eﬀects based on the models in
Table 4.I ti sc l e a rf r o mTable 5 that the spline eﬀects of pro-
thrombin time and bilirubin are strongly signiﬁcant. No
spline provides a signiﬁcantly better ﬁt than a linear model
forage.Thus,weaccepttheﬁnalmodel:age+s(pro)+s(bili)
withtheedf(eﬀectivedegreesoffreedom)3.954and4.477for
s(pro) and s(bili), respectively. We used likelihood ratio test
instead of information criteria as a valid alternative approach
for model selection. From Table 4, however, it is found that
the same ﬁnal model is selected by using AIC.
Figure 1showsthehistogramofthebootstrappedDev(b)
for the optimum model with B = 400. The bootstrap esti-
mate of the 95th percentile (i.e., 5% critical point) Dev∗
is Dev∗ = 734.59. Comparison to Dev = 663.65 of (15)
suggests that the model ﬁts the data.
Figure 2 shows the prediction of the probability of sur-
viving beyond the next six months for dead patient #9. For
the purpose of comparison, the results obtained using partial
logistic regression, the Mayo updated, and the European new
0
50
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500 550 600 650 700 750 800 850 900
Dev(b)
F
r
e
q
u
e
n
c
y
Figure 1: Histogram of the bootstrapped Dev(b)f o rB = 400.
version models are also provided. Figure 2 also indicates that
the six-month survival probability predicted by GAM are
lower than those predicted by the other models. Because the
patient #9 died, the lower predicted probabilities are better.
The conditional probability Pr(t,Δt) of survival over a short
time interval Δt (say, six months) after time t during the
course of the disease can be predicted from data collected for
censored and dead data.
Forthegraphicalrepresentation,theindividualprobabil-
ities for predicted survival are averaged in order to compare
the Mayo updated model, the European new version model,
the partial logistic regression model, and GAM. We can pre-
dict the probability of survival over the following six months
using the four models with respect to data and censored data
out of 312 patients. For the group (g = 1) and the censored
group (g = 2), the probability of surviving over the next Δt
months is denoted by Pr
[g]
d (l,l+Δt) for the l-th clinic visit of
patient #d. The average probability of survival over the next
Δt monthsforthel-thclinicvisitofpatient#d ingroupg can
be estimated as
Sg(l) =
1
n
[g]
l
n
[g]
l  
d=1
Pr
[g]
d (l,l +Δt), g = 1,2,
l = 1,2,...,L,
(18)
where n
[g]
l is the total number of patients for the l-th clinic
visit in group g,a n dP r
[g]
d (l) is the survival function Pr(l)o f
patient #d at the time interval l in group g;s e e ,f o re x a m -
ple, Markus et al. [35], Marubini and Valsecchi [10], and
Thomsen et al. [36].
Figure 3 shows a comparison of the probability of sur-
vivaloverthenextsixmonthsusingthefourmodelswithres-
pect to dead and censored data among all 312 patients. The
ﬁgure clariﬁes that
(i) for the case of dead data, the six-month survival pro-
babilitiespredictedbyGAMarelowerthanthosepre-
dicted by the other models, and,
(ii) for the case of censored data, the diﬀerence among
the four models is very small.6 Computational and Mathematical Methods in Medicine
Table 4: Ranks and F values for nonparametric eﬀects.
No. Model Deviance d.f. CV (AIC)
I s(time) + s(age) + s(pro) + s(bili) 661.77 1933.16 691.99 (685.44)
II s(age) + s(pro) + s(bili) 663.65 1934.57 690.54 (684.52)
III s(time) + s(pro) + s(bili) 705.50 1933.93 739.03 (727.64)
IV Age + s(pro) + s(bili) 663.65 1934.57 690.51 (684.51)
VA g e + s(pro) + bili 686.63 1937.58 708.44 (701.46)
VI Age + pro + s(bili) 675.80 1938.02 696.53 (689.77)
Table 5: Test of signiﬁcance for spline eﬀects.
Spline eﬀect Δ d.f.
Age 0.0039 (Model IV-II) 0.005
Prothrombin time 12.15 (Model VI-IV) 3.45
Bilirubin 22.97 (Model V-IV) 3.01
1
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Figure 2: Probability of survival over the next six months using the
four models with respect to dead patient #9.
Figure 4 also shows the box and whisker plots of pro-
bability of survival over the next six months using GAM with
respect to dead data among all 312 patients. It should be
noted that the variance of probabilities of survival over the
nextsixmonthsismuchhigherinthefourthclinicvisitsthan
inotherclinicvisits.Anotherusefulideainouranalysisisthe
concept of competing risk. There is “liver transplantation” in
PBCdataascompetingrisk.Competingriskhasbeentreated
as censored data. By adding x
 d 
l4 as one of time-dependent
covariate for the liver transplantation, one can test the sig-
niﬁcance of liver transplantation. The covariate for liver
transplantation is taken as a binary variable (codes 0 before
liver transplantation, 1 at liver transplantation) as shown in
Giorgi and Gouvernet [16]a n dC r o w l e y[ 37]. Table 6 shows
the three types for the combination of “censored” and “liver
transplantation.” Table 7 shows the values of covariates for
liver-transplanted patient #5.
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Figure 3: Probability of survival over the next six months using the
four models with respect to dead and censored data among all 312
patients.
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Figure 4: Box and whisker plots of probability of survival over the
nextsixmonthsusingGAMwithrespecttodeaddataamongall312
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Table 6: Three types of “censored” and “liver transplantation.”
Dead patient Censored patient Liver-transplanted patient
δ
 d 
l Liver transplant δ
 d 
l Liver transplant δ
 d 
l Liver transplant
0 00000
. .....
. .....
1 00001
Table 7: Values of covariates for dead patient #5.
Time
interval l
Midpoint
day a
 9 
l
Age (year) x
 9 
l1
Prothrombin time
(sec) x
 9 
l2
Bilirubin
(mg/dL) x
 9 
l3
Liver
trans-plantation x
 9 
l4
1 99.5 38.11 10.9 3.4 0
2 295.0 38.65 10.7 1.9 0
3 580.0 39.18 10.5 2.5 0
4 933.5 40.21 11.4 5.7 0
5 1276.5 41.11 11.3 5.2 0
6 1480.0 42.09 13.9 19.0 1
Table 8: Test of signiﬁcance for covariates using model (19).
Covariate P-value
Age <0.0001
Prothrombin time <0.0001
Bilirubin <0.0001
In order to test the signiﬁcance of “liver transplantation,”
we consider two models:
Model IV: age + s(pro) + s(bili).
Model IV :a g e+s(pro) + s(bili) + liver transplantation.
The values of deviance and d.f. are given in Table 8.T h e
reductioninthevalueofdevianceis10.657 = 663.65−653.00
on 0.973 d.f. This is signiﬁcant at the 1% level.
For the purpose of the comparison, the hazard of the
cumulative incidence function (CIF) may be modeled in the
presence of competing risks. The model is based on
γ(t;x) = γ0(t)exp
⎡
⎣
I  
i=1
βixi
⎤
⎦, (19)
where t is the time of the last observation (not the midpoint
at the time interval l), γ is the hazard of the subdistribution,
and γ0 is the baseline hazard of the subdistribution ([38],
Section 6.2). The P values are summarized in Table 8 to test
the signiﬁcance for covariates using the model (19). From
Tables 3 and 8, there is little diﬀerence between our method
and the CIF.
4. Discussion
In this paper, we introduced the probabilistic interpretation
of GAM and constructed the maximum likelihood principle
of GAM for the analysis of survival data having time-de-
pendent covariates. We proposed the information criterion
Table 9: Deviance and d.f.
Model Deviance d.f.
IV 663.65 1934.57
IV  653.00 1934.00
based on the variant v-fold CV when choosing the opti-
mal smoothing parameters in application of GAM. Intro-
ducing the maximum likelihood principle into GAM, the
deviance allows us to test the goodness-of-ﬁt of GAM. The
proposed methods were illustrated by comparing the prob-
ability of survival over the next six months using the Mayo-
updated model, the European new version model, the partial
logistic regression model, and GAM with respect to dead
and censored data among PBC data. We expect that ﬂexible
methods for modeling survival data with time-dependent
covariates using machine learning theory such that support
vectormachinewillbeveryusefulinthisreal-worldcontexts;
see, for example, Hastie et al. [39]. Furthermore, smoothing
spline ANOVA models by Gu [40] will enable us to include
the interactions between the covariates.
We assume that there is only one cause of failure; that
is, the event is allowed to occur only once for each patient.
However, there is increasing interest to apply survival data
sets with multiple events per patient [8, 41]. Wei et al. [42]
analyzed bladder cancer data by modeling marginal distri-
butions of multivariate failure time with proportional haz-
ards models. The model may violate the proportional haz-
ards assumption, even when the overall data set does not
(Table 9). By modifying such as
δ
 d 
l =
⎧
⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎩
1 : recurrent event for patient #d
occurred at the time-interval l
0 : otherwise.
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Equation (11)b e c o m e s
lnL
 
β
 
=
n  
d=1
ld  
l=1
 
δ
 d 
ld lnh
 d 
ld +
 
1 −δ
 d 
ld
 
ln
 
1 − h
 d 
ld
  
.
(21)
Thus, the ideas presented in this paper can be extended to
identiﬁcation of prognostic factors relative to survival time
in the case that the same event may recur during a follow-up
s t u d y ,a n dc o v a r i a t e sv a l u e sc h a n g ew i t ht i m e .
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